AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Trypanosoma cruzi CRISPR/Cas9 System Plasmid, PUC_sgRNA

Detailed Technology Description
Applications Contains the empty sgRNA backbone sequence (tracrRNA, 82 bp)and is used as DNA template to amplify a specific sgRNA using a forward primerwith the protospacer sequence for gene targeting. Trypanosoma cruzi CRISPR/Cas9 System plasmids allow for theamplification of a specific sgRNA sequence or express cas9 to generateCRISPR-ablated, red/green fluorescent parasites. Trypanosomacruziis the agent of Chagas disease, which affects millions of people worldwide.Vaccines to prevent this disease are not available, and drug treatments are notcompletely effective. The study of the biology of this parasite through geneticapproaches will make possible the development of new preventive or treatmentoptions.
*Abstract

Reagent Description

 

Gene/Insert Name: tracrRNA sequence

Insert Size (bp): 82 bp

Species:   N/A

Fusion Proteins/Tags: N/A

Vector Backbone and Size (bp): pUCAmp; 3150 bp              

Cloning Site 5’: 5′ sequencing primer: M13_forward20_primer and M13_pUC_fwd_primer

Cloning Site 3’: 3′ sequencing primer: M13_reverse_primer and M13_pUC_rev_primer

Antibiotic Resistance: Ampicillin

High or Low Copy:   High

Grow in Standard E. coli @ 37oC? DH5alpha; 37°C

Selectable Markers: Neomycin (select with G418)

Recommended Storage Temperature:   -20oC

References

 

LanderN, Li ZH, Niyogi S, Docampo R. CRISPR/Cas9-Induced Disruption of ParaflagellarRod Protein 1 and 2 Genes in Trypanosomacruzi Reveals Their Role in Flagellar Attachment. mBIO. 2015.6(4): e01012-15.

Country/Region
USA

For more information, please click Here
Mobile Device